Refine
Year of publication
- 2019 (306) (remove)
Institute
- Fachbereich Medizintechnik und Technomathematik (69)
- Fachbereich Elektrotechnik und Informationstechnik (44)
- Fachbereich Luft- und Raumfahrttechnik (44)
- IfB - Institut für Bioengineering (44)
- Fachbereich Wirtschaftswissenschaften (34)
- Fachbereich Bauingenieurwesen (28)
- Fachbereich Energietechnik (27)
- Fachbereich Maschinenbau und Mechatronik (25)
- INB - Institut für Nano- und Biotechnologien (19)
- Fachbereich Chemie und Biotechnologie (16)
Has Fulltext
- no (306) (remove)
Document Type
- Article (119)
- Conference Proceeding (93)
- Part of a Book (42)
- Book (24)
- Other (9)
- Doctoral Thesis (5)
- Patent (5)
- Review (4)
- Conference: Meeting Abstract (2)
- Examination Thesis (1)
Keywords
- Digitalisierung (3)
- Datenschutz (2)
- Enterprise Architecture (2)
- Robotic Process Automation (2)
- Seismic design (2)
- Achilles tendon (1)
- Advanced driver assistance systems (ADAS/AD) (1)
- Aircraft design (1)
- Analytics (1)
- Arbeit 4.0 (1)
In comparison to crude oil, biorefinery raw materials are challenging in concerns of transport and storage. The plant raw materials are more voluminous, so that shredding and compacting usually are necessary before transport. These mechanical processes can have a negative influence on the subsequent biotechnological processing and shelf life of the raw materials. Various approaches and their effects on renewable raw materials are shown. In addition, aspects of decentralized pretreatment steps are discussed. Another important aspect of pretreatment is the varying composition of the raw materials depending on the growth conditions. This problem can be solved with advanced on-site spectrometric analysis of the material.
The discovery of human induced pluripotent stem cells reprogrammed from somatic cells [1] and their ability to differentiate into cardiomyocytes (hiPSC-CMs) has provided a robust platform for drug screening [2]. Drug screenings are essential in the development of new components, particularly for evaluating the potential of drugs to induce life-threatening pro-arrhythmias. Between 1988 and 2009, 14 drugs have been removed from the market for this reason [3]. The microelectrode array (MEA) technique is a robust tool for drug screening as it detects the field potentials (FPs) for the entire cell culture. Furthermore, the propagation of the field potential can be examined on an electrode basis. To analyze MEA measurements in detail, we have developed an open-source tool.
Suppose we have k samples X₁,₁,…,X₁,ₙ₁,…,Xₖ,₁,…,Xₖ,ₙₖ with different sample sizes ₙ₁,…,ₙₖ and unknown underlying distribution functions F₁,…,Fₖ as observations plus k families of distribution functions {G₁(⋅,ϑ);ϑ∈Θ},…,{Gₖ(⋅,ϑ);ϑ∈Θ}, each indexed by elements ϑ from the same parameter set Θ, we consider the new goodness-of-fit problem whether or not (F₁,…,Fₖ) belongs to the parametric family {(G₁(⋅,ϑ),…,Gₖ(⋅,ϑ));ϑ∈Θ}. New test statistics are presented and a parametric bootstrap procedure for the approximation of the unknown null distributions is discussed. Under regularity assumptions, it is proved that the approximation works asymptotically, and the limiting distributions of the test statistics in the null hypothesis case are determined. Simulation studies investigate the quality of the new approach for small and moderate sample sizes. Applications to real-data sets illustrate how the idea can be used for verifying model assumptions.
Betrifft Design : von historischen Zukunftsperspektiven zu gegenwärtigen Vergangenheitssehnsüchten
(2019)
Human induced pluripotent stem cells (hiPSCs) have shown to be promising in disease studies and drug screenings [1]. Cardiomyocytes derived from hiPSCs have been extensively investigated using patch-clamping and optical methods to compare their electromechanical behaviour relative to fully matured adult cells. Mathematical models can be used for translating findings on hiPSCCMs to adult cells [2] or to better understand the mechanisms of various ion channels when a drug is applied [3,4]. Paci et al. (2013) [3] developed the first model of hiPSC-CMs, which they later refined based on new data [3]. The model is based on iCells® (Fujifilm Cellular Dynamics, Inc. (FCDI), Madison WI, USA) but major differences among several cell lines and even within a single cell line have been found and motivate an approach for creating sample-specific models. We have developed an optimisation algorithm that parameterises the conductances (in S/F=Siemens/Farad) of the latest Paci et al. model (2018) [5] using current-voltage data obtained in individual patch-clamp experiments derived from an automated patch clamp system (Patchliner, Nanion Technologies GmbH, Munich).